Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
20 April 2015 |
Main ID: |
NCT02373020 |
Date of registration:
|
16/02/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Enteropathogenic Escherichia Coli (EPEC): Does it Have a Role in Colorectal Tumourigenesis?
EPEC |
Scientific title:
|
ROLE OF E COLI IN Colorectal Tumourigenesis |
Date of first enrolment:
|
January 2011 |
Target sample size:
|
500 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT02373020 |
Study type:
|
Observational [Patient Registry] |
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Egypt
| | | | | | | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients with colorectal carcinoma after have been diagnosed
Exclusion Criteria:
- Patients with inflammatory bowel disease (IBD) or macroscopic signs of inflammation
were excluded.
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Colorectal Carcinoma
|
Enteropathogenic Escherichia Coli .
|
Intervention(s)
|
Other: colonoscopic biopsies
|
Primary Outcome(s)
|
virulence genes: eaeA, bfpA and stx. PCR
[Time Frame: 1 week]
|
Secondary Outcome(s)
|
EPEC serogrouping:
[Time Frame: 1 week]
|
Strains: OF E COLI
[Time Frame: 1 week]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|